Explore Apicule’s comprehensive Active Pharmaceutical Ingredients (APIs) directory, designed to help pharmaceutical professionals identify, research, and source APIs used in the development and manufacture of finished drug products. Our database brings together information on a wide range of pharmaceutical APIs, including small molecules, peptides, biologics, fermentation-derived ingredients, natural and semi-synthetic compounds, and other specialized active ingredients.
Search and browse APIs by drug class, therapeutic category, development or commercial status, source, CAS number, molecular information, and other key attributes, and discover relevant API manufacturers, suppliers, and pharmaceutical companies worldwide. Whether you are involved in pharmaceutical procurement, formulation development, R&D, business development, regulatory affairs, or supply-chain sourcing, Apicule provides a centralized resource for evaluating active ingredients and identifying potential manufacturing and supply partners.
Use the directory to research established commercial APIs, off-patent pharmaceutical ingredients, specialty APIs, and emerging or investigational drug substances, and access individual API pages containing available technical, regulatory, commercial, and supplier information. Apicule’s goal is to make API discovery and pharmaceutical ingredient sourcing faster, more transparent, and more efficient for drug manufacturers, sourcing professionals, CDMOs, distributors, and other participants across the global pharmaceutical industry.
An Active Pharmaceutical Ingredient (API) is the substance in a pharmaceutical drug that produces the intended therapeutic or pharmacological effect. APIs are used in the manufacture of finished dosage forms such as tablets, capsules, injections, creams, and oral liquids. A finished medicine may contain one or more APIs along with inactive ingredients known as excipients.
An API is the active drug substance, while a finished pharmaceutical product (FPP) is the final dosage form administered to a patient. For example, the active ingredient may be manufactured as a pharmaceutical-grade powder and later formulated with excipients into a tablet, capsule, injection, suspension, or other finished dosage form.
APIs may be classified by their manufacturing source or technology, including synthetic APIs, semi-synthetic APIs, fermentation-derived APIs, natural-source APIs, biotechnology-derived APIs, peptides, oligonucleotides, and inorganic or mineral-based APIs. They may also be classified by therapeutic category, pharmacological class, dosage application, or regulatory status.
APIs can be manufactured through processes such as chemical synthesis, fermentation, biotechnology, extraction from natural sources, peptide synthesis, or other specialized manufacturing technologies. Manufacturing typically involves multiple reaction or processing steps followed by purification, isolation, drying, testing, packaging, and quality release under appropriate pharmaceutical quality systems.
India and China are major global centers for API manufacturing, supported by extensive chemical and pharmaceutical manufacturing infrastructure. Significant API production also occurs in Europe, the United States, Japan, South Korea, and other regions. The geographic source of an API may vary substantially depending on manufacturing complexity, cost, technology, regulatory requirements, and intellectual-property considerations.
API manufacturers are expected to operate under appropriate Good Manufacturing Practice (GMP) systems covering areas such as personnel, facilities, equipment, documentation, materials management, production controls, laboratory testing, validation, change control, deviation management, storage, and distribution. ICH Q7 is an internationally recognized GMP framework specifically addressing API manufacturing.
A Certificate of Analysis (CoA) is a quality document that reports the analytical test results for a specific batch of an API. It typically identifies the product and batch and includes tests such as identity, assay, purity, impurities, moisture, residual solvents, and other applicable specifications. The CoA helps demonstrate whether a batch meets its established release requirements.
An API manufacturer physically produces the active ingredient. An API supplier is a broader term that may include manufacturers or companies supplying APIs to customers. A distributor purchases or represents APIs and resells them within particular markets, while a trader typically facilitates commercial transactions between buyers and manufacturers or other suppliers without manufacturing the API.
Important considerations include API quality, GMP compliance, manufacturing capability, regulatory history, supply reliability, production capacity, documentation, impurity profile, technical support, geographic risk, lead time, pricing, intellectual-property status, and experience supplying regulated pharmaceutical markets. Supplier selection should be based on both quality and commercial risk rather than price alone.
Specialized pharmaceutical directories such as Apicule can help buyers search for Active Pharmaceutical Ingredient manufacturers and suppliers by API, company, manufacturing location, and other relevant criteria. An API directory can simplify supplier discovery and support pharmaceutical sourcing teams in identifying potential manufacturers before conducting regulatory, technical, quality, and commercial qualification.
